NDC product
AMLODIPINE, VALSARTAN, HYDROCHLOROTHIAZIDE
NDC 64380-201 · Strides Pharma Science Limited
Key facts
| Product NDC | 64380-201 |
|---|---|
| Proprietary name | AMLODIPINE, VALSARTAN, HYDROCHLOROTHIAZIDE |
| Nonproprietary name | amlodipine besylate valsartan hydrochlorothiazide |
| Substances | AMLODIPINE BESYLATE, HYDROCHLOROTHIAZIDE, VALSARTAN |
| Dosage form | TABLET, FILM COATED |
| Route | ORAL |
| Labeler | Strides Pharma Science Limited |
| Product type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Application number | ANDA201087 |
| Pharmacologic classes | Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC] and 4 more |
| Marketing start | Jun 27, 2022 |
| Listing certified through | Dec 31, 2026 |
At a glance
- 1–9 Package NDCs
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About National Drug Codes (NDC)
The National Drug Code (NDC) is the FDA's product identifier for drugs; the product NDC identifies the labeler and product, and each package adds a package code.
Source: U.S. Food and Drug Administration (FDA), National Drug Code Directory · Source date: